CN103655571B - 一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 - Google Patents
一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 Download PDFInfo
- Publication number
- CN103655571B CN103655571B CN201210335108.7A CN201210335108A CN103655571B CN 103655571 B CN103655571 B CN 103655571B CN 201210335108 A CN201210335108 A CN 201210335108A CN 103655571 B CN103655571 B CN 103655571B
- Authority
- CN
- China
- Prior art keywords
- lopinavir
- ritonavir
- grams
- nanometer
- parallelism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
名称 | 量(克) |
洛匹那韦 | 200 |
利托那韦 | 50 |
聚氧乙烯40氢化蓖麻油 | 10 |
羟丙基纤维素SL | 230 |
蔗糖 | 250 |
微晶纤维素小球 | 250 |
硬脂酸镁 | 10 |
总计 | 1000 |
名称 | 量(克) |
洛匹那韦 | 100 |
利托那韦 | 25 |
月桂山梨坦 | 50 |
羟丙基甲基纤维素E3 | 25 |
羧甲基纤维素钠 | 12 |
微晶纤维素 | 25 |
滑石粉 | 13 |
纯化水 | 1000 |
总计 | 1250 |
名称 | 量(克) |
洛匹那韦 | 100 |
利托那韦 | 25 |
聚山梨醇80 | 10 |
羟丙基纤维素SL | 30 |
羧甲基纤维素钠 | 25 |
微晶纤维素RC591 | 50 |
滑石粉 | 25 |
纯化水 | 400 |
总计 | 665 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210335108.7A CN103655571B (zh) | 2012-09-11 | 2012-09-11 | 一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210335108.7A CN103655571B (zh) | 2012-09-11 | 2012-09-11 | 一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103655571A CN103655571A (zh) | 2014-03-26 |
CN103655571B true CN103655571B (zh) | 2016-04-20 |
Family
ID=50295133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210335108.7A Active CN103655571B (zh) | 2012-09-11 | 2012-09-11 | 一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103655571B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108066344A (zh) * | 2016-11-16 | 2018-05-25 | 北京万全德众医药生物技术有限公司 | 一种包含洛匹那韦及利托那韦的口服混悬制剂 |
CN108309950A (zh) * | 2017-01-17 | 2018-07-24 | 上海星泰医药科技有限公司 | 格列美脲纳米微丸制剂及其制备方法 |
CN114515268A (zh) * | 2022-02-21 | 2022-05-20 | 上海宣泰医药科技股份有限公司 | 熊去氧胆酸药物组合物及其制备方法和药物制剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) * | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US20050048112A1 (en) * | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
US8216495B2 (en) * | 2008-03-25 | 2012-07-10 | Formac Pharmaceuticals N.V. | Preparation method for solid dispersions |
EP2279728A1 (en) * | 2009-07-31 | 2011-02-02 | Ranbaxy Laboratories Limited | Solid dosage forms of HIV protease inhibitors |
GB201006038D0 (en) * | 2010-04-12 | 2010-05-26 | Unilever Plc | Improvements relating to antiviral compositions |
-
2012
- 2012-09-11 CN CN201210335108.7A patent/CN103655571B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103655571A (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020183426A (ja) | 共沈によるサブミクロン範囲内の非晶質固体分散物の製造方法 | |
Yi et al. | A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs | |
Li et al. | Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique | |
JP6033945B2 (ja) | アピキサバン製剤 | |
Shah et al. | Melt extrusion with poorly soluble drugs | |
Shah et al. | Development of novel microprecipitated bulk powder (MBP) technology for manufacturing stable amorphous formulations of poorly soluble drugs | |
RU2238089C2 (ru) | Фармацевтическая фенофибратная композиция, обладающая высоким биологическим потенциалом, и способ ее получения | |
Sun et al. | Nimodipine semi-solid capsules containing solid dispersion for improving dissolution | |
EA028009B1 (ru) | Фармацевтическая композиция с улучшенной биодоступностью | |
CN103655571B (zh) | 一种洛匹那韦和利托那韦复方高均匀度纳米共分散体及其制备方法 | |
Xue et al. | A combined utilization of Plasdone-S630 and HPMCAS-HF in ziprasidone hydrochloride solid dispersion by hot-melt extrusion to enhance the oral bioavailability and no food effect | |
CN103479643A (zh) | 一种用于治疗高血压的复方制剂的制备方法 | |
Yi et al. | Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose | |
Al-Zoubi et al. | Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions | |
Kasashima et al. | Oral sustained-release suspension based on a lauryl sulfate salt/complex | |
CN102106826A (zh) | 一种阿立哌唑固体制剂及其制备方法 | |
CN114302712A (zh) | 一种阿昔莫司多单元缓释微丸片及其制备方法 | |
WO2012088992A1 (zh) | 一种药物固体制剂的制备方法及所得药物固体制剂 | |
CN102106824B (zh) | 一种右旋佐匹克隆固体制剂及其制备方法 | |
CN108042495A (zh) | 一种格列吡嗪脂质纳米粒固体制剂 | |
Atneriya et al. | In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol | |
CN114533735A (zh) | 盐酸鲁拉西酮药物组合物及其制备方法 | |
Song et al. | Development of a sustained-release microcapsule for delivery of metoprolol succinate | |
Bashir et al. | Enhancing dissolution of artesunate from immediate release tablets using a green granulation technique | |
CN102106808B (zh) | 一种固体制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 201210 Shanghai Pudong New Area China (Shanghai) free trade test area No. 1999 Zhang Heng Road No. 7 Patentee after: Shanghai Double Star Thai Pharmaceutical Technology Co., Ltd. Address before: 201203 Shanghai city Pudong New Area Bing Road No. 306 building 3 floor No. 1 Patentee before: SHANGHAI SUNTECH PHARMACEUTICAL CO., LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210409 Address after: 201210 building 7, 1999 zhangheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP Co.,Ltd. Address before: 201210 building 7, 1999 zhangheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee before: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. |